Jessica Johnson, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1420 N 10th St, Spearfish, SD 57783 Phone: 605-717-8595 |
Gregory Larson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 550 E Colorado Blvd, Spearfish, SD 57783 Phone: 605-717-8860 |
Mark Stephen Heine, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2479 E Colorado Blvd, Spearfish, SD 57783 Phone: 605-644-4460 Fax: 605-644-4461 |
Jeffrey A Schild, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 1420 N 10th St, Spearfish, SD 57783 Phone: 605-717-8595 Fax: 605-642-8618 |
Joanne Millis, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2479 E Colorado Blvd, Spearfish, SD 57783 Phone: 605-644-4460 Fax: 605-644-4461 |
Jami Kortan, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1445 North Ave, Spearfish, SD 57783 Phone: 605-644-4170 Fax: 605-644-4198 |
Wesley W Broeder, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2479 E Colorado Blvd, Spearfish, SD 57783 Phone: 605-644-4460 Fax: 605-644-4461 |
Lynette R Siewert, PAC Physician Assistant Medicare: Medicare Enrolled Practice Location: 550 Colorado Blvd, Spearfish, SD 57783 Phone: 605-642-2030 Fax: 605-642-8338 |
News Archive
People with Merkel cell, gynecological, gastric and head and neck cancers may be eligible to participate in a clinical trial at Sanford Health testing the effectiveness of an investigational drug called nivolumab.
Senior Brandeis research scientist Daniel Perlman has discovered a way to make phytosterol molecules from plants dispersible in beverages and foods that are consumed by humans, potentially opening the way to dramatic reductions in human cholesterol levels.
Rats with regular access to cannabis seek more of the substance and tend to show increased drug-seeking behavior when cannabis is absent.
News outlets explore different issues related to Medicare, including the impact the physician payment system has on patients' access and the particular challenges posed by people who qualify for both Medicare and Medicaid.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration to market Aztreonam for Injection, USP in two dosage strengths. Aztreonam is therapeutically equivalent to the reference-listed drug Azactam, which is marketed by Bristol-Myers Squibb.
› Verified 9 days ago